|
Name |
Griseophenone C
|
| Molecular Formula | C16H16O6 | |
| IUPAC Name* |
(2,6-dihydroxy-4-methoxyphenyl)-(4-hydroxy-2-methoxy-6-methylphenyl)methanone
|
|
| SMILES |
CC1=CC(=CC(=C1C(=O)C2=C(C=C(C=C2O)OC)O)OC)O
|
|
| InChI |
InChI=1S/C16H16O6/c1-8-4-9(17)5-13(22-3)14(8)16(20)15-11(18)6-10(21-2)7-12(15)19/h4-7,17-19H,1-3H3
|
|
| InChIKey |
XZDCIORWACLZKX-UHFFFAOYSA-N
|
|
| Synonyms |
Griseophenone C; MEGxm0_000310; CHEMBL4128685; ACon0_001032; ACon1_001487; CHEBI:81997; ZINC14647533; NCGC00180454-01; C18836; BRD-K80248306-001-01-2; Q27155677; (2,6-dihydroxy-4-methoxyphenyl)-(4-hydroxy-2-methoxy-6-methylphenyl)methanone; NCGC00180454-03!(2,6-dihydroxy-4-methoxyphenyl)-(4-hydroxy-2-methoxy-6-methylphenyl)methanone
|
|
| CAS | NA | |
| PubChem CID | 23757122 | |
| ChEMBL ID | CHEMBL4128685 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 304.29 | ALogp: | 3.1 |
| HBD: | 3 | HBA: | 6 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 96.2 | Aromatic Rings: | 2 |
| Heavy Atoms: | 22 | QED Weighted: | 0.751 |
| Caco-2 Permeability: | -5.184 | MDCK Permeability: | 0.00000937 |
| Pgp-inhibitor: | 0.005 | Pgp-substrate: | 0.031 |
| Human Intestinal Absorption (HIA): | 0.03 | 20% Bioavailability (F20%): | 0.406 |
| 30% Bioavailability (F30%): | 0.793 |
| Blood-Brain-Barrier Penetration (BBB): | 0.028 | Plasma Protein Binding (PPB): | 99.08% |
| Volume Distribution (VD): | 0.582 | Fu: | 2.88% |
| CYP1A2-inhibitor: | 0.959 | CYP1A2-substrate: | 0.932 |
| CYP2C19-inhibitor: | 0.248 | CYP2C19-substrate: | 0.068 |
| CYP2C9-inhibitor: | 0.486 | CYP2C9-substrate: | 0.906 |
| CYP2D6-inhibitor: | 0.494 | CYP2D6-substrate: | 0.863 |
| CYP3A4-inhibitor: | 0.748 | CYP3A4-substrate: | 0.196 |
| Clearance (CL): | 13.327 | Half-life (T1/2): | 0.685 |
| hERG Blockers: | 0.049 | Human Hepatotoxicity (H-HT): | 0.045 |
| Drug-inuced Liver Injury (DILI): | 0.946 | AMES Toxicity: | 0.618 |
| Rat Oral Acute Toxicity: | 0.192 | Maximum Recommended Daily Dose: | 0.91 |
| Skin Sensitization: | 0.636 | Carcinogencity: | 0.05 |
| Eye Corrosion: | 0.007 | Eye Irritation: | 0.971 |
| Respiratory Toxicity: | 0.403 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002470 | ![]() |
0.690 | D07MGA | ![]() |
0.364 | ||
| ENC000936 | ![]() |
0.662 | D06GCK | ![]() |
0.333 | ||
| ENC002375 | ![]() |
0.618 | D04AIT | ![]() |
0.300 | ||
| ENC005979 | ![]() |
0.615 | D0B0AX | ![]() |
0.287 | ||
| ENC004806 | ![]() |
0.615 | D0K8KX | ![]() |
0.280 | ||
| ENC002683 | ![]() |
0.597 | D0C6DT | ![]() |
0.273 | ||
| ENC006012 | ![]() |
0.597 | D01XNB | ![]() |
0.273 | ||
| ENC005938 | ![]() |
0.577 | D0W7JZ | ![]() |
0.271 | ||
| ENC006073 | ![]() |
0.573 | D02XJY | ![]() |
0.271 | ||
| ENC005978 | ![]() |
0.556 | D09GYT | ![]() |
0.269 | ||